Viewing Study NCT01189903


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-28 @ 1:45 AM
Study NCT ID: NCT01189903
Status: UNKNOWN
Last Update Posted: 2014-01-28
First Post: 2010-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients
Sponsor: National University Hospital, Singapore
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CR01/18/10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators